pharmaceutical investing Salarius Pharmaceuticals Enrolls First Patient in a Phase 1 Clinical Study of its Novel Inhibitor
CHARBONE Hydrogene annonce la cloture d'une deuxieme et derniere tranche de son placement prive sursouscrit sans intermediaire de 1 M$
CHARBONE Hydrogen Announces Closing of a Second and Final Tranche, Oversubscribing its $1M Non-Brokered Private Placement
